^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    DCIKKb

    i
    Other names: Vaccination with IKKb matured Dendritic Cells, DCIKKb, Dendritic Cell vaccine
    Associations

    News

    Trials
    Company:
    Hasumi International Research Foundation, ICVS Tokyo Clinic
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    2years
    IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma (clinicaltrials.gov)
    P1, N=12, Active, not recruiting, Hasumi International Research Foundation | Recruiting --> Active, not recruiting | Trial completion date: Jun 2025 --> Jan 2024 | Trial primary completion date: Jun 2022 --> Jan 2023
    Enrollment closed • Trial completion date • Trial primary completion date
    |
    CD4 (CD4 Molecule)
    |
    DCIKKb